Skip to main content
. 2023 Mar 28;55(1):1262–1286. doi: 10.1080/07853890.2023.2191218

Figure 4.

Figure 4.

Melatonin regulates insulin secretion in pancreatic β-cells via the cAMP, cGMP and IP3 signaling pathways [98,236]. The binding of melatonin to MT1 inhibits cyclic adenosine monophosphate (cAMP) signaling and decreases insulin secretion in pancreatic β-cells. The binding of melatonin to MT2 inhibits cyclic guanosine monophosphate (cGMP) signaling and decreases insulin secretion in pancreatic β-cells. Melatonin stimulates IP3 release accompanied by a transient increase in Ca2+ concentrations and leads to Ca2+-dependent insulin secretion. Figure 3 was created with BioRender (https://biorender.com).